We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.00 | -0.10% | 1,992.00 | 1,992.00 | 1,994.00 | 2,004.00 | 1,985.00 | 1,991.00 | 10,599 | 08:38:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 23.01 | 4.42B |
Date | Subject | Author | Discuss |
---|---|---|---|
04/11/2016 15:18 | looks odd IMO....directors been buying in massive size 25% above this price....is it overdone? Am not involved yet, but watching with interest as to when may be a time to dip in! | qs99 | |
04/11/2016 09:18 | I think this is more than negative sector sentiment ahead of the US election.... | tanners | |
04/11/2016 09:11 | Not a holder but had wondered myself as I have them on my watchlist but overall the pharma sector is under the cosh in expectation of a Clinton win as a result I will not be buying any pharma stocks prior to the election. I had Glaxo and sold after the rally which was purely due to £ weakness. | salpara111 | |
04/11/2016 09:10 | Interim management statement due on 10th November. | tanners | |
04/11/2016 09:01 | EDIT - oops I'm going mad! I read somewhere trading update due and thought it said 5th November, but obviously not - I'll recheck! | tanners | |
04/11/2016 09:00 | Does anybody know why the shares have tumbled this morning? | chrisgail | |
25/10/2016 07:11 | Trying to understand the daily 50 p falls..Is it being played on the US election. Why this co..? Directors are millions down in total on their recent purchases. what does it he market know that they don't?? | sandeep67 | |
21/10/2016 12:26 | Sold out rather make a profit then see it turn into a loss may buy in again | mrthomas | |
21/10/2016 09:42 | Any thoughts that this might be to do with the likelihood that Clinton is going to be president and will prevent price gouging by pharma on products. Suspect that HIKMA price is badly influenced. Whereas HIK are producing generics mostly I gther. | gertie2shoes | |
21/10/2016 04:10 | Thinking of selling as from 50% gain to less than 10% not sure why this is the case all in less than 6/8 months | mrthomas | |
20/10/2016 22:13 | Us legislation? | r ball | |
04/10/2016 08:59 | Hope springs eternal. | r ball | |
09/9/2016 10:11 | Someone explain how repeated multi million pound share purchases over last weeks have contributed to daily declines in s/p. I nolonger understand this part | sandeep67 | |
05/9/2016 10:35 | well not really sure what to make of this share was up 50% a few weeks ago now about 20% think that its still in FT 100 so that helps | mrthomas | |
01/9/2016 18:42 | No. Boehringer potential and Luke warm product lanches | r ball | |
01/9/2016 13:58 | 3 directors spent millions on shares each yesterday. Looks like Institutions want in by dropping the price to encourage scared selling. Can't see why the share price is inversing against the huge guys | sandeep67 | |
01/9/2016 13:05 | This share is getting too up and down for me now thinking of selling just hope stays up n FT 100 other wise will g down even more | mrthomas | |
24/8/2016 08:24 | well there you go. Naff results by share price up. Got to be on target for £30 now. | r ball | |
23/8/2016 21:19 | Tomorrow is another day? | r ball | |
07/8/2016 13:41 | Problem is the management discloses very little and this is the third time they've messed up in a year. First they said their gout treatment was fine and two months later they warned on it. Then they said actually 2015 revenues for Roxane were much lower than expected and so they got a massive discount on the purchase price. Now they are saying 2016 revenues from this generics business will miss. Clearly a pattern here.....but if you want to take the risk then good luck. I'd rather in invest in a company that gives more discoloured and whose management know how to forecast. | rrb | |
06/8/2016 11:49 | should still be in the FT100 so the good and as you said good recovery not sure what the fuss was about still I think a long term hold | mrthomas | |
05/8/2016 11:21 | great recovery | gucci | |
04/8/2016 09:46 | Numis downgrade- target price about where it was yesterday. | greenpastures2 | |
04/8/2016 09:20 | Steady, or, boring, to put it another way maybe exactly what might be good to be invested in over the next year or two. They are growing the business at a very steady rate, it remains a long term hold in any portfolio. | chrisgail |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions